Neo-Bionica is a company that specializes in the product realization of bioelectric medical devices, focusing on targeted therapies and diagnostics. They are involved in the development and manufacturing of implantable and wearable electronics, as well as electrodes for neuromonitoring and neuromodulation devices. The company was established to address the gap in medical device prototype manufacturing capabilities, particularly in the design and production of robust implantable electrodes. Neo-Bionica also assists clients in accessing Australian R&D incentive programs.

Neo-Bionica bridges the gap between research and the clinic, providing world-class engineering expertise and links to leading clinicians to create life changing medical device solutions. Offering end-to-end medical device prototype development, from initial concept and rapid prototyping, to pre-clinical testing and first-in-human prototypes for clinical trials



Neo-Bionica

Neo-Bionica is proud to sponsor the "BCI: State of the Art, Art of the Future" panel discussion at #EMBC2024 on July 18, 2024 in Orlando, Florida. Join executives from Blackrock Neurotech, Motif Neurotech, ONWARD Medical, Paradromics Inc., Precision Neuroscience, and Synchron. Register to attend at https://lnkd.in/efw6dcH8

Neo-Bionica is very excited to be part of the neurotech ecosystem, supporting innovative start-ups such as BrainConnect in developing brain chip technology.
 
This technology holds great potential to significantly change the way we monitor, diagnose, and potentially treat neurological conditions.
 
Learn more about BrainConnect's AURA® technology, it's collaboration with Neo-Bionica, and BrainConnect's future plans from its co-founder, Associate Professor, Omid Kavehei

Neo-Bionica was delighted to host a breakfast in Adelaide recently, bringing together industry leaders to support and celebrate the Australian neurotech ecosystem.

Australia has world-leading expertise in neurotech, and it takes a village to nurture this expertise and build companies and products that reach the market and transform people’s lives.

Thank you to all who joined us. We look forward to continuing to work together to strengthen the ecosystem and build innovative MedTech companies that change lives.
#Neurotech #MedTech #Innovation #Community #NeoBionica

Neo-Bionica welcomes two new non-executive directors to its board, Stephane Chatonsky and Colin White
 
“I am delighted to have Stéphane and Colin join the Neo-Bionica board. Their extensive expertise in innovation in MedTech, strategy and capital raising will be invaluable to Neo-Bionica as we enter our next phase of growth both domestically and internationally.” Dr Ludovic Labat, CEO Neo-Bionica

COM:NEO-BIONICA

Neo-Bionica

Analysis Not Available